UCSF Chancellor Desmond-Hellmann Talks Academic Partnerships
This article was originally published in The Pink Sheet Daily
Executive Summary
At Bio-Windhover's Pharmaceutical Strategic Outlook conference, Susan Desmond-Hellmann discussed UCSF's evolving relationships with big pharma.
You may also be interested in...
Leaving UCSF, Desmond-Hellman Will Become Gates Foundation CEO
Ex-Genentech executive Susan Desmond-Hellman soon will leave her position as UCSF chancellor to become CEO of the Gates Foundation. Her move signals the foundation’s ambition to lead in the science and the financing of neglected and tropical diseases, as well as in the global alliances that enable both.
Spurred By Necessity, Industry And Academia Are Learning To Share
After a prior era of failed collaborations, industry and academia are increasingly joining forces in ways that better accommodate each others’ capabilities and goals – and, they hope, will create more value and ultimately greater improvements to human health.
Spurred By Necessity, Industry And Academia Are Learning To Share
After a prior era of failed collaborations, industry and academia are increasingly joining forces in ways that better accommodate each others’ capabilities and goals – and, they hope, will create more value and ultimately greater improvements to human health.